Related Experiment Video
Updated: Jan 20, 2026

Electrophysiological Recording of The Central Nervous System Activity of Third-Instar Drosophila Melanogaster
Published on: November 21, 2018
Central nervous system emergencies in haematological malignancies
Macarena I de la Fuente1, Juan Pablo Alderuccio2, Izidore S Lossos2,3
1Departments of Neurology and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Neurological emergencies in hematological malignancies (HM) require prompt recognition and treatment to prevent severe outcomes. This review covers CNS complications, their management, and treatment-related neurological issues in HM patients.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- Neurological emergencies are severe complications in hematological malignancies (HM).
- These events can lead to fatal outcomes or long-term disabilities if not managed promptly.
- They often occur during disease relapse and lack established management guidelines.
Purpose of the Study:
- To review the pathophysiology, clinical presentation, and treatment strategies for central nervous system (CNS) complications in HM.
- To discuss neurological issues arising from both traditional and novel HM treatments.
Main Methods:
- Literature review of existing studies and clinical guidelines.
- Synthesis of information on various CNS complications and treatment-related neurological effects.
Main Results:
- Key CNS complications include elevated intracranial pressure, spinal cord compression, status epilepticus, neurovascular issues, CNS infections, leukostasis, and hyperviscosity.
- Neurological complications are also associated with the expanding spectrum of HM treatments.
Conclusions:
- There is a critical need for standardized practice guidelines for managing CNS complications in HM.
- Comprehensive understanding of these neurological emergencies is vital for improving patient outcomes in hematological malignancies.
Related Concept Videos
06:45Electrophysiological Recording of The Central Nervous System Activity of Third-Instar Drosophila Melanogaster
14:55Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
11:28Culturing Microglia from the Neonatal and Adult Central Nervous System
02:21Generation of a Murine Model with a Central Nervous System Infection
10:28Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY
Intrathecal Delivery of a Test Compound to the Rat Central Nervous System

